| 产品描述: | Cdc 选择性抑制剂;Cdc Selective Inhibitors;产品介绍NG 52 是一种有效的,选择性的 ATP 兼容且具有口服活性的 Cdc28p 和 Pho85p 激酶抑制剂,IC50 分别为 7 μM 和 2 μM。NG 52 还以 IC50 值为 2.5 μM 来抑制磷酸甘油酸激酶 1 (PGK1) 的活性。NG 52 对酵母激酶 Kin28p,Srb10 和 Cak1p 无活性。;InformationNG-52 is a tri-substituted purine that binds to the ATP-binding site of yeast cyclin-dependent kinases, inhibiting Cdc28p and Pho85p with IC50s of 7 and 2 μM, respectively.TargetsPho85p (Cell-free assay); Cdc28p (Cell-free assay) 2 μM; 7 μM |
| 体内研究: |
NG 52 (50-150 mg/kg;口服给药;每天;持续 13 天) 抑制剂量依赖性地抑制神经胶质瘤异种移植物的生长。 |
| 参考文献: |
1. ray NS, Wodicka L, Thunnissen AM et al. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science. 1998 Jul 24;281(5376):533-8. 2. Wen-Liang Wang, et al. Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52. Acta Pharmacol Sin. 2020 Jul 31. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.883 ml |
14.417 ml |
28.834 ml |
| 5 mM |
0.577 ml |
2.883 ml |
5.767 ml |
| 10 mM |
0.288 ml |
1.442 ml |
2.883 ml |
| 50 mM |
0.058 ml |
0.288 ml |
0.577 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |